LC Pharma Concept SRL
LC Pharma Concept reported total assets of 13,961 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of LC Pharma Concept shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -43 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LC Pharma Concept's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 05 Aug 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
LC Pharma Concept's financial analysis
- Solvency32.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LC Pharma Concept
LC Pharma Concept's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0729.811.271
- VAT number
- BE0729811271
- Peppol
- Registered · 0208:0729811271 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Jul 2019
- Registered office
- 7160 Chapelle-lez-Herlaimont
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
LC Pharma Concept (SRL) has been based in Chapelle-lez-Herlaimont since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 3,805 € and equity of 4,546 €; its revenue is not published. Its solvency stands at 32.6%, below the median of its sector (41.5%).
Companies similar to LC Pharma Concept
Companies in the same business, of comparable size and area, outside its group.
- Lorena Boulanger Pharma Retail sale of pharmaceutical products Chapelle-lez-Herlaimont · balance sheet 32,165 €
- AU Pave D' Ollignies Retail sale of pharmaceutical products Mouscron · balance sheet 7,469 €
- Farmaco Retail sale of pharmaceutical products Ranst · balance sheet 17,325 €
- TVB Consult Retail sale of pharmaceutical products Kruisem · balance sheet 17,370 €
- Camille Huby Retail sale of pharmaceutical products Etterbeek · balance sheet 18,562 €
- PharmaSave Retail sale of pharmaceutical products Antwerp · balance sheet 20,063 €
- Croixssance Pharma Retail sale of pharmaceutical products Zaventem · balance sheet 9,474 €
- Kasibel Retail sale of pharmaceutical products Uccle · balance sheet 20,641 €
Frequently asked questions about LC Pharma Concept
What is the revenue of LC Pharma Concept?
LC Pharma Concept files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LC Pharma Concept?
In Belgium, the VAT number is the company number prefixed with BE: BE0729811271 for LC Pharma Concept, if the company is VAT-registered. Its company number (CBE) is 0729.811.271.
Where is the registered office of LC Pharma Concept?
According to the CBE register, the registered office of LC Pharma Concept is in 7160 Chapelle-lez-Herlaimont.
What is the equity of LC Pharma Concept?
At the close of the 2025 financial year, the equity of LC Pharma Concept amounts to 4,546 €, a solvency of 32.6% of total assets.
Who manages LC Pharma Concept?
The register lists 1 active mandates at LC Pharma Concept. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LC Pharma Concept
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →